Clinical Trials Browser

Phase 2 × OTHER × Staining and Labeling × Clear all

NCT01328535 2020-10-22

Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Phase 2 Completed

25 enrolled 8 charts

Melanoma